The global “genomics market size” is projected to reach USD 62614.6 million by 2026. Genomics has successfully transformed the way of preventing, managing and treating diseases. Researchers at the University of Paris-Saclay believe that we have entered into the third revolution of sequencing technology in the world of genetics. Moreover, several companies are planning to build third-generation sequencing technology to stay abreast of new trends. As per a recent report published by Fortune Business Insights, titled “Genomics Market Size, Share and Industry Analysis By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Regional Forecast, 2019 – 2026,” the market value stood at USD 15888.8 million in 2018 and is anticipated to exhibit an exponential CAGR of 18.7% during the forecast period.
Leading Players operating in the Genomics Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Thermo Fisher Scientific Inc.
- Oxford Nanopore Technologies
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941
Advancements in Bioinformatics to Boost the Market in North America
Among regions, North America is anticipated to emerge dominant in the global genomics market throughout the forecast years. In 2018, the market value stood at USD 6959.3 million. This is ascribable to the rising focus on pharmacogenomics and technological advancements in bioinformatics. This, coupled with increasing adoption of new sequencing technologies, will create growth opportunities for the market in this region. Rising preference for personalized medicines is another factor responsible for the dominance of market in this region.
Apart from North America, the market in Europe is expected to exhibit a higher CAGR owing to the robust support from governments, especially in the U.K. Asia Pacific is expected to hold a considerable genomics market share over the projected horizon. Factors such as increasing the aging population, high demand for genetic sequencing in China, and expansion of healthcare system are positively impacting the genomics market growth in this region.
The report covers:
- Global Genomics Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
Detailed Table of Content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4 Market Trends
- Key Insights
4.1 Genomics Research Spending – For Key Countries, 2018
4.2 Regulatory Scenario – For Key Countries
4.3 Overview of Genomics Service Provider
4.4 New Product Launch
4.5 Start-upswith their Funding Overview
4.5Key Industry Developments – Mergers, Acquisitions and Partnerships
- Global Genomics Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Type
184.108.40.206 Instruments& Software
5.3. Market Analysis, Insights and Forecast – By Technology
5.3.1 Polymerase Chain Reaction (PCR)
5.3.2 Next-generation Sequencing (NGS)
5.3.4 Sanger Sequencing
5.4. Market Analysis, Insights and Forecast – By Application
5.5. Market Analysis, Insights and Forecast – By End User
5.5.1 Research Institutes
5.5.2 Healthcare Facilities & Diagnostic Centers
5.5.3 Pharmaceutical& Biotechnological Companies
5.5.4 Contract Research Organization (CROs)
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1 North America
5.6.3 Asia Pacific
5.6.4 Latin America
5.6.5MiddleEast & Africa
- North America Genomics Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Type
220.127.116.11 Instruments& Software
6.3. Market Analysis – By Technology
6.3.1 Polymerase Chain Reaction (PCR)
6.3.2 Next-generation Sequencing (NGS)
6.3.4 Sanger Sequencing
6.4. Market Analysis – By Application
6.4. Market Analysis – By End User
6.5.1 Research Institutes
6.5.2 Healthcare Facilities & Diagnostic Centers
6.5.3 Pharmaceutical& Biotechnological Companies
6.5.4 Contract Research Organization (CROs)
6.6. Market Analysis – By Country
- Europe Genomics Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Type
18.104.22.168 Instruments& Software
7.3. Market Analysis – By Technology
7.3.1 Polymerase Chain Reaction (PCR)
7.3.2 Next-generation Sequencing (NGS)
7.3.4 Sanger Sequencing
7.4. Market Analysis – By Application
7.5. Market Analysis – By End User
7.5.1 Research Institutes
7.5.2 Healthcare Facilities & Diagnostic Centers
7.5.3 Pharmaceutical& Biotechnological Companies
7.5.4 Contract Research Organization (CROs)
7.5. Market Analysis – By Countries/ Sub regions
- Asia Pacific Genomics Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Type
22.214.171.124 Instruments& Software
8.3. Market Analysis – By Technology
8.3.1 Polymerase Chain Reaction (PCR)
8.3.2 Next-generation Sequencing (NGS)
8.4. Market Analysis – By Application
8.5. Market Analysis – By End User
8.5.2HealthcareFacilities & Diagnostic Centers
8.5.3Pharmaceutical& Biotechnological Companies
8.5.4ContractResearch Organization (CROs)
8.6. Market Analysis – By Countries/ Sub regions
8.6.6Restof Asia Pacific
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/genomics-market-100941
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Genomics Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report updates
Reasons to Purchase this Report:
- Comprehensive analysis of the Genomics Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245